Torthaí cuardaigh - Rob E. Aarnoutse

Beachtaigh na torthaí
  1. 1
    Implications of the global increase of diabetes for tuberculosis control and patient care

    Implications of the global increase of diabetes for tuberculosis control and patient care de réir Rovina Ruslami, Rob E. Aarnoutse, Bachti Alisjahbana, André van der Ven, Reinout van Crevel

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development de réir Jossy van den Boogaard, Gibson Kibiki, Elton R. Kisanga, Martin J. Boeree, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study

    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study de réir Jossy van den Boogaard, Ramsey A. Lyimo, Martin J. Boeree, Gibson Kibiki, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program

    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program de réir J. A. H. Droste, Rob E. Aarnoutse, Peter P. Koopmans, Yechiel A. Hekster, David M. Burger

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients

    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients de réir Rovina Ruslami, Hanneke M. J. Nijland, Bachti Alisjahbana, Ida Parwati, Reinout van Crevel, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children

    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children de réir Lisa C. Martial, Rob E. Aarnoutse, Michiel F. Schreuder, Stefanie Henriet, Roger J. M. Brüggemann, Manuela Joore

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients de réir Alma Tostmann, Charles Mtabho, Hadija Semvua, Jossy van den Boogaard, Gibson Kibiki, Martin J. Boeree, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review

    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review de réir Alma Tostmann, Martin J. Boeree, Rob E. Aarnoutse, Wiel C.M. de Lange, André van der Ven, Richard Dekhuijzen

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Intensified antibiotic treatment of tuberculosis meningitis

    Intensified antibiotic treatment of tuberculosis meningitis de réir Fiona V Cresswell, Lindsey te Brake, Rachel Atherton, Rovina Ruslami, Kelly E. Dooley, Rob E. Aarnoutse, Reinout van Crevel

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients de réir Erlina Burhan, Carolien Ruesen, Rovina Ruslami, Arum Ginanjar, Hadiarto Mangunnegoro, Purwantyastuti Ascobat, Rogier Donders, Reinout van Crevel, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis de réir Hanneke M. J. Nijland, Rovina Ruslami, A. J. Suroto, David M. Burger, Bachti Alisjahbana, Reinout van Crevel, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses de réir Robin J. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Martin J. Boeree, Ulrika S. H. Simonsson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes de réir Rovina Ruslami, Hanneke M. J. Nijland, I. Gusti N. Adhiarta, S.H.K.S. Kariadi, Bachti Alisjahbana, Rob E. Aarnoutse, Reinout van Crevel

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1

    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1 de réir Nurul Annisa, Nadiya Nurul Afifah, Prayudi Santoso, Vycke Yunivita, Lindsey H. M. te Brake, Rob E. Aarnoutse, Melisa Intan Barliana, Rovina Ruslami

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis

    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis de réir Jan‐Willem C. Alffenaar, Richard van Altena, H. J. Bökkerink, Gert Jan Luijckx, Dick van Soolingen, Rob E. Aarnoutse, Tjip S. van der Werf

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials

    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials de réir Elin M. Svensson, Sofiati Dian, Lindsey te Brake, Ahmad Rizal Ganiem, Vycke Yunivita, Arjan van Laarhoven, Reinout van Crevel, Rovina Ruslami, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia

    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia de réir Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, Firda Shafira Nurfadila, Kevin Aprilio, Rizky Abdulah, Bony Wiem Lestari, Rovina Ruslami, Trisasi Lestari, Rob E. Aarnoutse

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations

    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations de réir Robin J. Svensson, Elin M. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Vineshree Mischka Moodley, Martin J. Boeree, Ulrika S. H. Simonsson

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP

    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP de réir Vincent J. Lempers, Jeroen J. M. W. van den Heuvel, Frans G. M. Rüssel, Rob E. Aarnoutse, David M. Burger, Roger J. M. Brüggemann, Jan J. Koenderink

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience de réir Arianna D. Pranger, Richard van Altena, Rob E. Aarnoutse, Dick van Soolingen, D. R. A. Uges, Jos G.W. Kosterink, Tjip S. van der Werf, Jan‐Willem C. Alffenaar

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: